BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 32553252)

  • 1. Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography Substudy.
    Makkar RR; Blanke P; Leipsic J; Thourani V; Chakravarty T; Brown D; Trento A; Guyton R; Babaliaros V; Williams M; Jilaihawi H; Kodali S; George I; Lu M; McCabe JM; Friedman J; Smalling R; Wong SC; Yazdani S; Bhatt DL; Bax J; Kapadia S; Herrmann HC; Mack M; Leon MB
    J Am Coll Cardiol; 2020 Jun; 75(24):3003-3015. PubMed ID: 32553252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study.
    Chakravarty T; Søndergaard L; Friedman J; De Backer O; Berman D; Kofoed KF; Jilaihawi H; Shiota T; Abramowitz Y; Jørgensen TH; Rami T; Israr S; Fontana G; de Knegt M; Fuchs A; Lyden P; Trento A; Bhatt DL; Leon MB; Makkar RR; ;
    Lancet; 2017 Jun; 389(10087):2383-2392. PubMed ID: 28330690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamics and Subclinical Leaflet Thrombosis in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement.
    Khan JM; Rogers T; Waksman R; Torguson R; Weissman G; Medvedofsky D; Craig PE; Zhang C; Gordon P; Ehsan A; Wilson SR; Goncalves J; Levitt R; Hahn C; Parikh P; Bilfinger T; Butzel D; Buchanan S; Hanna N; Garrett R; Shults C; Garcia-Garcia HM; Kolm P; Satler LF; Buchbinder M; Ben-Dor I; Asch FM
    Circ Cardiovasc Imaging; 2019 Dec; 12(12):e009608. PubMed ID: 31826675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of subclinical leaflet thrombosis affecting motion in bioprosthetic aortic valves.
    Sondergaard L; De Backer O; Kofoed KF; Jilaihawi H; Fuchs A; Chakravarty T; Kashif M; Kazuno Y; Kawamori H; Maeno Y; Bieliauskas G; Guo H; Stone GW; Makkar R
    Eur Heart J; 2017 Jul; 38(28):2201-2207. PubMed ID: 28838044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study.
    Blanke P; Leipsic JA; Popma JJ; Yakubov SJ; Deeb GM; Gada H; Mumtaz M; Ramlawi B; Kleiman NS; Sorajja P; Askew J; Meduri CU; Kauten J; Melnitchouk S; Inglessis I; Huang J; Boulware M; Reardon MJ;
    J Am Coll Cardiol; 2020 May; 75(19):2430-2442. PubMed ID: 32234463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical leaflet thrombosis following transcatheter aortic valve replacement.
    Kanjanauthai S; Pirelli L; Nalluri N; Kliger CA
    J Interv Cardiol; 2018 Oct; 31(5):640-647. PubMed ID: 29790209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoattenuated leaflet thickening (HALT) and reduced leaflet motion (RELM) of aortic bioprostheses: An imaging finding or a complication?
    Ahmad Y; Makkar R; Sondergaard L
    Prog Cardiovasc Dis; 2022; 72():78-83. PubMed ID: 35675882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement.
    Jang MH; Ahn JM; Kang DY; Kim KW; Koo HJ; Yang DH; Jung SC; Kim B; Wong YTA; Lam CCS; Yin WH; Wei J; Lee YT; Kao HL; Lin MS; Ko TY; Kim WJ; Kang SH; Ko E; Lee SA; Kim DH; Kim H; Choi Y; Lee J; Park SJ; Park DW
    Heart; 2023 Dec; 110(2):140-147. PubMed ID: 37586823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leaflet thrombosis following transcatheter aortic valve implantation.
    Marwan M; Mekkhala N; Göller M; Röther J; Bittner D; Schuhbaeck A; Hell M; Muschiol G; Kolwelter J; Feyrer R; Schlundt C; Achenbach S; Arnold M
    J Cardiovasc Comput Tomogr; 2018; 12(1):8-13. PubMed ID: 29195844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and Late Leaflet Thrombosis After Transcatheter Aortic Valve Replacement.
    Yanagisawa R; Tanaka M; Yashima F; Arai T; Jinzaki M; Shimizu H; Fukuda K; Watanabe Y; Naganuma T; Higashimori A; Mizutani K; Araki M; Tada N; Yamanaka F; Otsuka T; Yamamoto M; Hayashida K
    Circ Cardiovasc Interv; 2019 Feb; 12(2):e007349. PubMed ID: 30732472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical predictors and sequelae of computed tomography defined leaflet thrombosis following transcatheter aortic valve replacement at medium-term follow-up.
    Rashid HN; Michail M; Ihdayhid AR; Dowling C; Khav N; Tan S; Ramnarain J; Cameron JD; Nasis A; Nicholls SJ; Gooley RP
    Heart Vessels; 2021 Sep; 36(9):1374-1383. PubMed ID: 33660057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation Therapy After Transcatheter Aortic Valve Replacement.
    Chakravarty T; Jilaihawi H; de la Rosa A; Makkar R
    Curr Cardiol Rep; 2020 Oct; 22(12):175. PubMed ID: 33040213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioprosthetic valve oversizing is associated with increased risk of valve thrombosis following TAVR.
    Simpson TF; Tuohy CV; Rajotte K; Golwala H; Fuss C; Song HK; Zahr F; Chadderdon SM
    Catheter Cardiovasc Interv; 2021 Feb; 97(3):E411-E417. PubMed ID: 32633055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypo-Attenuated Leaflet Thickening and Reduced Leaflet Motion in Sutureless Bioprosthetic Aortic Valves.
    Dalén M; Sartipy U; Cederlund K; Franco-Cereceda A; Svensson A; Themudo R; Svenarud P; Bacsovics Brolin E
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter Aortic Valve Replacement and Impact of Subclinical Leaflet Thrombosis in Low-Risk Patients: LRT Trial 4-Year Outcomes.
    Waksman R; Bhogal S; Gordon P; Ehsan A; Wilson SR; Levitt R; Parikh P; Bilfinger T; Hanna N; Buchbinder M; Asch FM; Kim FY; Weissman G; Ben-Dor I; Shults CC; Ali S; Sutton JA; Shea C; Zhang C; Garcia-Garcia HM; Satler LF; Rogers T
    Circ Cardiovasc Interv; 2023 May; 16(5):e012655. PubMed ID: 37192308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Bioprosthetic Heart Valve Thrombosis After Transcatheter Aortic Valve Replacement: Incidence, Characteristics, and Treatment Outcomes.
    Jose J; Sulimov DS; El-Mawardy M; Sato T; Allali A; Holy EW; Becker B; Landt M; Kebernik J; Schwarz B; Richardt G; Abdel-Wahab M
    JACC Cardiovasc Interv; 2017 Apr; 10(7):686-697. PubMed ID: 28385406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of Incidence, Predictors and Consequences of Clinical and Subclinical Bioprosthetic Leaflet Thrombosis After Transcatheter Aortic Valve Implantation.
    Sannino A; Hahn RT; Leipsic J; Mack MJ; Grayburn PA
    Am J Cardiol; 2020 Oct; 132():106-113. PubMed ID: 32773221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging Evaluation for the Detection of Leaflet Thrombosis After Transcatheter Aortic Valve Replacement.
    Zhao ZG; Wang MY; Jilaihawi H
    Interv Cardiol Clin; 2018 Jul; 7(3):293-299. PubMed ID: 29983142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Evaluation for Hypoattenuated Leaflet Thickening Following Transcatheter Aortic Valve Implantation.
    Tang L; Lesser JR; Schneider LM; Burns MR; Gössl M; Garberich R; Niikura H; Witt D; Sorajja P
    Am J Cardiol; 2019 Feb; 123(4):658-666. PubMed ID: 30528421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke.
    Vollema EM; Kong WKF; Katsanos S; Kamperidis V; van Rosendael PJ; van der Kley F; de Weger A; Ajmone Marsan N; Delgado V; Bax JJ
    Eur Heart J; 2017 Apr; 38(16):1207-1217. PubMed ID: 28369242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.